PRFX — PainReform Cashflow Statement
0.000.00%
Last trade - 00:00- $4.45m
- $0.19m
Annual cashflow statement for PainReform, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.05 | -7.25 | -8.79 | -9.34 | -14.6 |
| Depreciation | |||||
| Non-Cash Items | 2.37 | 1.22 | 1.65 | 1.03 | 0.304 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.869 | -0.538 | 0.672 | 1.62 | 1.65 |
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -2.56 | -6.55 | -6.46 | -6.68 | -12.6 |
| Capital Expenditures | -0.01 | -0.05 | -0.006 | -0.009 | -0.013 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -6 | 6 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.01 | -0.05 | -6.01 | 5.99 | -0.013 |
| Financing Cash Flow Items | — | 6 | 0 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.3 | 7.48 | 0 | 4.62 | 8.86 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14.7 | 0.881 | -12.5 | 3.93 | -3.77 |